Mandeg, Anacel M.

HRN: 06-08-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
CEFUROXIME 1.5GM (VIAL)
11/13/2022
11/20/2022
IV
1.5 Gms
On Call To OR
For Scheduled Curettage
Waiting Final Action 
11/14/2022
CEFUROXIME 500MG (TAB)
11/14/2022
11/21/2022
ORAL
500mg
BID
D&C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: